Kapitalisasi marang bathi Longboard Pharma (LBPH)
The market trend for Longboard Pharmaceuticals (LBPH) reflects the dynamics of a company developing advanced, patent-protected treatments for epilepsy and severe brain pathologies. The current indicator stands at -27.00. Despite reliance on a single primary project, significant capital ensures financial stability. The brand's high medical authority is based on effective trials and providing aid to patients with rare diagnoses.
Rincian analitis perusahaan Longboard Pharmaceuticals
- kuotasi lan prakiraan analis:
- rincian kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Longboard Pharmaceuticals|LBPH - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Longboard|LBPH - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Longboard Pharmaceuticals, Inc.|LBPH - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Longboard Pharmaceuticals|Rasio likuiditas darurat longboardpharma.com
- rincian asil keuangan lan kelipatan valuasi:
LBPH - Penghasilan resik|Penghasilan resik sing dikarepake Longboard Pharmaceuticals|LBPH - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Longboard Pharmaceuticals Inc|LBPH - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Longboard Pharmaceuticals, Inc.|LBPH - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Longboard Pharmaceuticals|LBPH - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan longboardpharma.com|LBPH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Longboard Pharmaceuticals
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:LBPH, longboardpharma.com
The P/E ratio measures the market value of a single unit of net profit, determining the investment payback period. This metric compares current market capitalization with the actual profitability of the business. By monitoring P/E fluctuations, an investor can see the impact of the acquisition of Longboard Pharmaceuticals (LBPH) by a European behemoth on asset valuation. The integration of the pipeline into the buyer's structure renders classic earnings analysis secondary. The indicator now serves as a marker for the completion of the M&A transaction.
Analisis perusahaan pesaing
Rasio rega marang bathi BIIB|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|RGC - Kapitalisasi marang bathi|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|ACAD: Pangali rega marang bathi|Xenon Pharmaceuticals - Pangali P/E|Rasio kapitalisasi marang bathi resik vikingtherapeutics.com (VKTX)|SUPN: Pangali P/E|CPRX (Catalyst Pharma) - Rasio rega marang bathi|Rasio rega marang bathi Denali Therapeutics Inc|Kapitalisasi marang bathi Harmony Corp HRMY|Pangali P/E BHVN|Pangali P/E amylyx.com (AMLX)|Rasio rega marang bathi Trevi Therapeutics, Inc. TRVI|Nilai perusahaan marang bathi resik PRAX|Anavex Corp - Pangali P/E|CBLL (CeriBell EEG) - Pangali rega marang bathi|PRTA (prothena.com) - Koefisien rega marang bathi|Alector - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Annexon|Omeros Corp. - Kapitalisasi marang bathi resik|Pangali P/E NGNE|ACIU (AC Immune Inc) - Nilai perusahaan marang bathi resik|Pangali P/E VYGR (Voyager Therapeutics)|Pangali P/E neumoratx.com NMRA|SCLX - Rasio rega marang bathi|Nilai perusahaan marang bathi resik TVGN (Tevogen Bio Holdings Inc.)|alphacognition.com (ACOG) - Rasio rega marang bathi|Koefisien rega marang bathi Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - Pangali P/E|Pangali P/E cassavasciences.com|Pangali P/E ASRT|Koefisien rega marang bathi coyatherapeutics.com COYA|Pangali P/E VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalisasi marang bathi|ABOS: Koefisien rega marang bathi|CRVO - Pangali P/E|ATHE (alteritytherapeutics.com) - Koefisien rega marang bathi|CLNN: Rasio rega pasar marang bathi resik|PEPG (PepGen Inc) - Pangali P/E|Jupiter Neurosciences, Inc. (JUNS) - Periode bali modal bisnis|Pangali P/E RLMD|Koefisien rega marang bathi annovisbio.com ANVS|Pangali P/E GRCE (Grace Therapeutics)|Pangali P/E Firefly Neuroscience, Inc. AIFF|KLTO - Rasio rega marang bathi|NRSN: Rasio rega marang bathi|Reviva Pharmaceuticals (RVPH) - Rasio rega marang bathi|MTVA - Periode bali modal bisnis|Rasio rega marang bathi NeurAxis|Rasio rega marang bathi HSDT|Pangali P/E PASG|Rasio rega marang bathi NEUP (bionomics.com.au)|Rasio rega marang bathi Minerva Neurosciences NERV|ATHA (athira.com) - Kapitalisasi marang bathi resik|Addex Therapeutics Ltd - Pangali P/E|Nilai perusahaan marang bathi resik ALZN (Alzamend Neuro, Inc.)|cyclerion.com (CYCN) - Rasio rega marang bathi|Pangali rega marang bathi PTIX|KTTA (Pasithea Therapeutics Corp) - Pangali P/E|Kapitalisasi marang bathi Cortigent Medical CRGT|Koefisien rega marang bathi ATXI (Avenue Therapeutics, Inc.)|Pangali P/E Brainstorm Cell Therapeutics Inc. (BCLI)|Rasio rega marang bathi Cara Therapeutics, Inc CARA|Nilai perusahaan marang bathi resik CHRO|ELYM - Rasio rega marang bathi|Kapitalisasi marang bathi Intra-Cellular Therapies|Marinus Pharmaceuticals, Inc. (MRNS) - Rasio rega marang bathi|NKGN (NKGen Biotech Inc) - Rasio rega marang bathi|Rasio rega marang bathi NeuroBo|Kapitalisasi marang bathi Sage Therapeutics Inc SAGE|Rasio rega marang bathi Synaptogenix, Inc. (SNPX)|trevena.com - Pangali rega marang bathi|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|Rasio kapitalisasi marang bathi resik anewmeds.com|Cerevel - Pangali P/E
